Preparation of Mycobacterium smegmatis porin A (MspA) nanopores for single molecule sensing of nucleic acids

Mycobacterium smegmatis porin A (MspA) is a conical shaped octameric biological nanopore. It contains a rigid 16-stranded β-barrel structure, which contributes to its thermal and chemical stability (Faller et al. 2004). It was reported that functional MspA pores stay active at a temperature up to 90 °C, within a pH range from 0–14, or in the presence of various denaturing agents (Heinz et al. 2003a). MspA also has an advantageous geometry for sensing. Briefly, the crystal structure reveals that the pore constriction measures just ~1.2 nm in diameter and 0.6 nm in length, fitting perfectly to the size of a single nucleotide on a strand of ssDNA (Derrington et al. 2010). This high spatial resolution has enabled MspA to achieve a single base resolution in the first demonstration of nanopore sequencing (Manrao et al. 2012). Moreover, in recent studies (Cao et al. 2019, 2021; Wang et al. 2020), highly engineered MspA nanopores were applied as a single molecule nanoreactors benefiting from its high spatial resolution of sensing and an overall conical geometry which fully amplifies perturbations caused by binding of an analyte, down to a single atomic ion. However, successful employment of engineered MspAs is only limited to few academic groups. This is in part because the reported methods of MspA preparation are not detailed enough to follow. By prokaryotic expression followed with purification by nickel affinity chromatography, our laboratory is capable of producing more than ten types of MspA mutants. A wide variety of corresponding applications including single molecule sensing (Cao et al. 2019, 2021; Wang et al. 2018, 2019b, 2020) and sequencing (Wang et al. 2019a; Yan et al. 2019; Zhang et al. 2020) were consequently reported. However, a detailed protocol describing how an MspA nanopore is prepared has not yet been disclosed, to the best of our knowledge.

MspA belongs to a family of four very similar porins in Mycobacterium smegmatis. As the dominant porin in Mycobacterium smegmatis strains, MspA can be directly isolated from the bacterial lysates assisted with mild detergents at a room temperature. However, the yield and purity are not satisfying (Niederweis et al. 1999). By lysing Mycobacterium smegmatis with nonionic detergents at a temperature over 90 °C and purifying the treated lysate with anion exchange and size-exclusion chromatography (Heinz and Niederweis 2000), the yield is 20-fold increased, reporting a 20-μg protein production from a 1-L culture volume. For further structural studies by NMR or X-ray crystallography, optimized codons were introduced to the MspA gene as recombinant proteins when expressed by E. coli host cells. In this way, a yield of milligram MspA was achieved by multi-step chromatography, including anion exchange chromatography, hydrophobic interaction chromatography and size-exclusion chromatography (Heinz et al. 2003b; Sun et al. 2020). However, these preparation procedures are rather complicated, setting a high technical barrier for other interested researchers who may lack a required expertise of protein purifications.

Based on a previously published method developed by us (Cao et al. 2019, 2021; Wang et al. 2018, 2020), we present a highly simplified and effective protocol to prepare MspA and its functional mutants. This protocol is based on E. coli prokaryotic expression followed with one-step chromatography purification. A His-tag is incorporated into the recombinant protein to simplify the purification. During purification, the nonionic surfactant Genapol X-080 and a high lysing temperature are employed to promote the solvation of MspA. As an example of application, a nucleic acid immobilization assay was performed with the prepared MspA.

This tutorial protocol provides a step-by-step guide for MspA preparation and application. This preparation method can easily produce milligram quantities of MspA nanopores with a high stability, activity and reproducibility. Although not be demonstrated, other MspA mutants could in principle be prepared in the same way.

The method for MspA preparation offers a high yield and purity but limited in the throughput. Because the employment of ÄKTA pure protein purification system only permits the purification of one type of MspA recombinant protein at a time. This may be inefficient to simultaneously screen a large variety of MspA mutants. A His-tag is required for nickel affinity purification. However, the addition of a His-tag to the C-terminus of the gene is not interfering with the sensing ability of MspA.

In this protocol, the M2 MspA mutant (D90N/D91N/D93N/D118R/D134R/E139K), which has been widely applied in nanopore sequencing or as an engineering template to build nanoreactors, is employed as an example. For simplicity, this mutant is referred to as MspA throughout the paper, if not otherwise stated. The whole protocol consists of four steps, including MspA overexpression, purification, characterization by single channel recording and the DNA immobilization assay. Firstly, the gene coding for a monomeric MspA with a His-tag on its C-terminus is cloned into a pET-30a(+) plasmid. The plasmid is transformed to E. coli BL21 (DE3) for protein expression. After culture, the cells are lysed in the presence of Genapol X-080 at 60 °C and centrifuged to remove the cell debris. During cell lysis, the monomeric MspA spontaneously oligomerizes into a tightly bound octameric form. The produced MspA octamer can be purified by Ni-affinity column by elution with a concentration gradient of imidazole (Fig. 1A). The fractions containing the MspA octamer are collected and characterized by 4%–20% SDS PAGE (Fig. 1B). To evaluate the activity and repeatability of the prepared MspA nanopores, single molecule characterizations can be performed, including continuous pore insertion (Fig. 2A), open pore current statistics (Fig. 2B) and current–voltage (I–V) curve measurement (Fig. 2C). Finally, single molecule discrimination between ploy C and ploy T using MspA is demonstrated as a tutorial application (Fig. 3A–3E).

The pET system is frequently applied for the expression of recombinant proteins in E. coli (Studier and Moffatt 1986). The pET vectors carry a chromosomal copy of the T7 RNA polymerase gene under lacUV5 control, which can be induced with isopropyl-β-D thiogalactoside (ITPG). The kanamycin resistance introduced to the pET vectors is useful to screen the transformed colonies. By enzymatic treatment with NdeI and HindIII, the gene coding for the MspA mutant containing a His-tag on its C-terminus is cloned to a pET-30a(+) plasmid. For simplicity, the successfully constructed plasmid is also shared on a public repository operated by Genescript (New Jersey). The readers can simply follow the link: https://www.molecularcloud.org/plasmid/M2-MspA/MC-0101191.html to request the plasmid.

E. coli BL21 (DE3), a widely used T7 expression E. coli strain (Schlegel et al. 2012), is employed for protein expression. The plasmid coding for MspA is transformed into E. coli BL21 (DE3) and cultured in a lysogeny broth (LB) agar plate containing kanamycin. A single colony of transformed cells is then selected for culture in the LB broth. When the cell culture has reached an optical density at 600 nm (OD₆₀₀) of 0.7, IPTG is added to induce protein expression.

The purpose of this step is to extract MspA from the cell membrane. Genapol X-080, a widely applied non-ionic detergent, is critical to lyse the cell membrane to assist MspA solubilization. Due to the thermal stability of MspA, a high temperature can as well be applied to remove a large proportion of impurity proteins which are not thermal stable.

His-Tag, composed of six histidines (Loughran and Walls 2011), is widely applied as a tag of recombinant proteins. It has a small molecular weight, which does not affect the structure and function of most target proteins. Commercial Nickel-affinity column immobilizes nickel ions on the chromatographic medium by chelating ligand nitazotriacetic acid (NTA) or iminodiacetic acid (IDA). Nickel ions can coordinate with the imidazole group of histidine, making the target protein with a His-Tag adsorbed on the affinity column. During purification, the binding buffer A, which contains 5 mmol/L imidazole, is firstly applied to elute nonspecifically adsorbed proteins from the column. Then a linear gradient of elution buffer B, which contains 500 mmol/L imidazole, is applied to elute MspA protein (Fig. 1A).

The measurement device consists of two custom poly-formaldehyde chambers separated by a ~20 μm-thick Teflon film. An aperture with a diameter of ~100 μm is located in the middle of the Teflon film. The aperture is firstly treated with 0.5% (v/v) pentane solution of hexadecane and air dried to fully evaporate the pentane. During the measurements, both chambers are filled with KCl electrolyte buffer. A pair of Ag/AgCl electrodes is applied to generate the desired voltages across the membrane. After the addition of a drop of lipid to each chamber, the buffer level in one of the chambers was lowered and restored repetitively to form the lipid bilayer. As a transmembrane protein, MspA in the buffer would spontaneously insert into the lipid bilayer, forming the only channels connecting the two chambers. To avoid further pore insertions, the buffer should be quickly exchanged with fresh ones. All electrophysiology measurements are then performed with an Axopatch 200B patch clamp amplifier paired with a Digidata 1550B digitizer. Recordings are sampled at 25 kHz and low-pass filtered with a 1-kHz cutoff frequency.

As a demo of application, we performed single molecule discrimination of two terminal biotin modified ssDNA oligonucleotides, namely ploy C (3’-TEG-biotin-C₂₂ CCT GTC TCC CTG CCG CCT GTC TCC CTG CCG-5’) and ploy T (3’-TEG-biotin-T₂₂ CCT GTC TCC CTG CCG CCT GTC TCC CTG CCG-5’). The biotin-tags allow the oligonucleotides to be tethered with a streptavidin stopper, forming a streptavidin-DNA complex. Assisted with the streptavidin, which is too large to translocate through the pore, the oligonucleotides can be electrophoretically immobilized in the pore, reporting a long residing residual current (Fig. 3A) (Manrao et al. 2011; Stoddart et al. 2009). Consequently, poly C and ploy T, which produces different residual currents, are distinguished (Fig. 3E).

Step 1: Plasmid transformation

Thaw 100 μL E. coli BL21 (DE3) competent cells on ice for 30 min. Mix 1 μL 100 ng/μL MspA plasmid into 100 μL competent cells. Gently mix by finger flicking the bottom of the tube for several times. Incubate the mixture on ice for 30 min. Heat shock the cells on a metal bath set at 42 °C for 90 s and quickly place the cells back on ice for 3–5 min.

[CRITICAL STEP] Competent cells are fragile, so all operations should be done gently and avoid violent shaking.

[CRITICAL STEP] In order to avoid introduction of other molds or fungus, operations shall be performed on a biosafety cabinet and all equipment should be sterilized by UV exposure prior to each use.

Step 2: Spreading plate

Place all transformed cells on a LB agar plate containing kanamycin. Spread evenly with a glass drigalski spatula (triangle-shaped). Invert the petri dish and culture in a thermostatic incubator at 37 °C for 18–20 h.

[CRITICAL STEP] Operations shall be performed in a biosafety cabinet and all equipment should be sterilized by UV exposure prior to each use.

Step 3: Culturing a single colony

Pick a single colony from the LB agar plate with a 200 μL-tip and add it to a flask containing 100 mL LB broth. Top the flask with a breathable sealing film to maintain the oxygen level in the culture without getting environmental contaminations. Culture in an oscillating incubator at 200 r/min for 5–6 h at 37 °C.

[CRITICAL STEP] A desired spread plate should contain a countable number of isolated colonies evenly distributed on the plate. Carefully pick a colony and avoid introducing surrounding colonies.

[CRITICAL STEP] Operations shall be performed on a biosafety cabinet and all equipment should also be sterilized by UV before use.

[? TROUBLESHOOTING]

Step 4: Induction expression of target fusion protein

Until the cells are grown to an OD₆₀₀ = 0.7, cool the culture down to the room temperature. Spare 1 mL cell culture for sequencing characterization. Add 100 μL 1 mol/L IPTG solution to the remaining cell culture to activate protein expression. Culture at 200 r/min for 12 h at 16 °C.

[CRITICAL STEP] If the bacteria grow too dense, the cells will inhibit the protein expression.

[CRITICAL STEP] Ensure that the plasmid sequencing result is correct before proceeding with subsequent purifications.

[CRITICAL STEP] Operations shall be performed on a biosafety cabinet and all equipment should be sterilized by UV prior to each use.

[? TROUBLESHOOTING]

Step 5: Cell lysis

Centrifuge the cells at 4000 r/min, for 20 min at 4 °C to remove the LB broth. Resuspend the cell pellet in a 10 mL lysis buffer and stir well. Heat at 60 °C in a metal bath for 20 min and keep it on ice for 10 min. Centrifuge the cells at 13,000 r/min for 40 min at 4 °C to remove nuclei, cell debris, and unbroken cells. Filter the protein supernatant with a 0.2-μm syringe filter to avoid clogging the Ni-affinity column.

Step 6: Purification of MspA with Ni-affinity chromatography

Set the flow rate at 1 mL/min. Elute the nickel column with 5 column volumes of Milli-Q, 5 column volumes of elution buffer B and 10 column volumes of binding buffer A successively. Load the protein supernatant manually. Set the flow rate at 4 mL/min. Remove the unbound protein with binding buffer A until the UV value is stable. Set the flow rate at 1 mL/min and collect the eluent at a rate of 1 mL/tube. Elute MspA protein using a linear gradient of 0–100% elution buffer over 30 column volumes within 30 min. Two major peaks will be observed in the spectrum (Fig. 1A).

[CRITICAL STEP] Solutions should be processed with vacuum filtration to avoid clogging the column.

[? TROUBLESHOOTING]

Step 7: Characterization of MspA with polyacrylamide gel electrophoresis

Collect the samples including the supernatants of the bacterial lysate before and after loading to Ni-affinity chromatography, the 11^th, 14^th, 15^th, 16^th and 17^th tubes of protein eluent. Load the samples on a 4%–20% SDS-polyacrylamide gel and then run for 27 min with a +200-V applied potential (Fig. 1B). Stain the gel with Commassie blue fast staining solution for 15–20 min and visualize it with gel imager system. Theoretically, the band around 100 kDa corresponds to the MspA octamer. After gel electrophoresis, measure MspA concentration using nanodrop and store it at −80 °C for future uses.

[? TROUBLESHOOTING]

Step 8: Preparation of Ag/AgCl electrodes

Solder a male pin and a piece of silver wire (~2 cm in length) at the two ends of a wire separately. Seal the welding joints with shrinkable tubes. Soak the silver wire in 30% (v/v) NaOCl (diluted in water) overnight until the silver surface is greyish black. Rinse the electrodes with Milli-Q and ethanol, air-dry with nitrogen gas and store away from light.

Step 9: Assemble of homemade measurement device

The measurement device consists of two mirror symmetrical modules, separated by a Teflon film. Each module is provided with a sample chamber (~500 μL) and three electrode holes. Breakdown an aperture (~100 μm in diameter) in the Teflon film using a homemade arc generator. Sandwich the Teflon film between the two modules with glues and fasten the two modules together with screws. Rest the assembly overnight until the glue has fully set. To enrich phospholipid molecules, point-coat a small amount of hexadecane solution around the hole with a capillary under the microscope before use.

[CRITICAL STEP] The both sides of the aperture should be tapped with hexadecane solution.

Step 10: Construction of detection system

Use AxoPatch 200B Amplifier and Axon Digidata 1500B for measurements. To shield mechanical and electromagnetic noise, place the measurement device inside a homemade Faraday cage, mounted on an optical table. Connect male pin ends of a pair of Ag/AgCl electrodes to Axopatch 200B Amplifier probes. Insert silver wire ends of the two Ag/AgCl electrodes to one of electrode holes of the two chambers. Conventionally, the chamber electrically grounded is defined as cis, and the opposing chamber is defined as trans.

Step 11: Formation of lipid bilayer

Add 500 μL KCl buffer to the cis and trans chambers separately. Respectively add a drop of lipid to both chambers using capillary. Switch to a +20 mV-constant voltage. Raise and drop the buffer in the chamber back and forth using a pipette. Repeat several times until the current changes from 19 nA (a short circuit) to 0 pA (a broken circuit). Switch to a triangle wave voltage protocol (Peak amplitude: ±50 mV, frequency: 5 Hz) to check the quality of the lipid bilayer. The bilayer capacitance can be determined according to $ C=I/(dV/dt) $, where “I” stands for the absolute current magnitude of the square wave signal. An ideal lipid bilayer usually generates a standard square wave current with amplitude range from 50 to 100 pA.

[? TROUBLESHOOTING]

Step 12: Single channel characterization of MspA

Add MspA nanopore to cis and stir well. Switch to a +100 mV-constant voltage. Record the process of successive pore insertions (Fig. 2A). When the current is unstable, break the lipid bilayer and pull it up again. Repeat until a total of about 100 pores have been recorded to form a statistic (Fig. 2B).

[? TROUBLESHOOTING]

Step 13: Insertion of single MspA nanopore in the lipid bilayer

Switch to a +20 mV-constant voltage. Add MspA nanopore to cis and stir well. Switch to a square wave voltage protocol (Peak amplitude: ±200 mV, frequency: 1 Hz) to facilitate pore insertion. Wait until a current stepping occurs. Switch to a 0 mV-constant voltage and adjust the current to zero. Switch to a +20 mV-constant voltage. If the open pore current is stable and appropriate (~64 pA), quickly exchange the buffer in cis with fresh KCl buffer for about 10 times to avoid further pore insertions. Switch to a triangle voltage (increasing from −150 mV to 150 mV at intervals of 10 mV and each voltage lasts for 500 ms). Record the I–V curve of MspA (Fig. 2C).

[? TROUBLESHOOTING]

Step 14: Recording background signal

Switch to a static blockade voltage protocol (+180 mV for 900 ms, −50 mV for 100 ms, 0 mV for 100 ms, circular 500 times). Record the current.

[? TROUBLESHOOTING]

Step 15: Sensing of immobilized poly C

Premix 3.8 μL poly C-biotin (100 μmol/L) and 20 μL streptavidin (1 mg/mL, 18.9 μmol/L). Switch to a +20 mV-constant voltage. Add 6.25 μL mixture of poly C-biotin and streptavidin in cis and stir well. Switch to the static blockade voltage protocol (+180 mV for 900 ms, −50 mV for 100 ms, 0 mV for 100 ms, circular 1000 times) and record the current (Fig. 3B).

[? TROUBLESHOOTING]

Step 16: Simultaneously sensing of immobilized poly C and ploy T

Premix 3.8 μL poly T-biotin (100 μmol/L) and 20 μL streptavidin (1 mg/mL, 18.9 μmol/L). Switch to a +20 mV-constant voltage. Add 6.25 μL mixture of poly T-biotin and streptavidin in cis and stir well. Switch to the static blockade voltage protocol (+180 mV for 900 ms, −50 mV for 100 ms, 0 mV for 100 ms, circular 1000 times) and record the current (Fig. 3D).

[? TROUBLESHOOTING]

Troubleshooting advice can be found in Table 1.

[TIMING]

Step 1: Plasmid transformation (~1 h)

Step 2: Cell culture in LB agar plate (18–20 h)

Step 3: Selection of single colony (~1 h); Cell culture in LB broth (5–6 h)

Step 4: Induction expression (~12 h)

Step 5: Cell lysis (~2 h)

Step 6: MspA purification (~3 h)

Step 7: Gel electrophoresis (~2 h)

Step 8: Preparation of Ag/AgCl electrodes (~1 h); Immersion in 30% (v/v) NaOCl (12 h)

Step 9: Preparation of measurement device (~1 h); Gel solidification (12 h)

Step 10: Construction of detection system (30 min)

Step 11: Formation of lipid bilayer (30 min)

Step 12: Single channel characterization of MspA (~1 h)

Step 13: Insertion of single MspA nanopore (~1 h)

Step 14: Recording background signal (10 min)

Step 15: Sample preparation (5 min); Recording signals of ploy C sensing (20 min)

Step 16: Sample preparation (5 min); Recording signals of ploy C and ploy T sensing (20 min)

Generally, the prepared MspA spontaneously oligomerize into an octameric form. Monomeric MspA is however rarely seen. During a gradient elution (Step 6), non-specific proteins and MspA octamers will be eluted in a sequential order. Two peaks, respectively around the 11^th and the 16^th fraction are expected to appear in the UV absorbance spectrum (Fig. 1A). Their identities are subsequently confirmed based on the gel electrophoresis results in Fig. 1B (Step 7). In denaturing polyacrylamide gels, the octameric MspA migrates equivalently to that of a molecular mass of 100 kDa, which could be found between the 14^th and the 17^th fractions.

The quality of the prepared MspA can be checked by single channel recording. After adding MspA to cis, spontaneous and successive pore insertion could be observed (Step 12, Fig. 2A). This indicates that MspA expressed in E. coli still has high pore-forming activity. The open pore current of each MspA shows a high consistency, the distribution of which follows a Gaussian fitting with a mean value of 295.39 pA at +100 mV (Step 12, Fig. 2B). The I–V curve acquired from a single MspA shows a general linear correlation between current and voltage (Step 13, Fig. 2C).

In the example of application, when attached to streptavidin and held within MspA, poly C and poly T can be clearly distinguished by reporting different residual currents ($ {I}_{\text{b}} $) (Fig. 3A). The open pore current ($ {I}_{\text{o}} $) of single MspA nanopore is usually around 554.20 pA at +180 mV. When ploy C-streptavidin complex was added to cis, successive blockade events with the same residual current was reported (Step 15, Fig. 3B). The distribution of $ {I}_{\text{b}} $ follows a Gaussian distribution centered at 110.35 pA (Fig. 3C). When ploy T-streptavidin complex was further added to cis, deeper blockades were observed (Step 16, Fig. 3D). Histogram plots of $ \Delta I $ also show two peaks centered at 69.19 pA and 112.90 pA, respectively corresponding to reading of ploy T and ploy C (Fig. 3E).

• MspA plasmid (Genscript, customized product)

• E. coli BL21 (DE3) competent cell (Biomed, cat. no. CC0703)

• Kanamycin (Beyotime, cat. no. ST008)

• IPTG (Solarbio, cat. no. I8070)

• LB broth (Hopebio, cat. no. 140665)

• LB Agar (Hopebio, cat. no. 140664)

• NaH₂PO₄ (Aladdin, cat. no. S817796)

• EDTA (Sigma-Aldrich, cat. no. 324504)

• NaCl (Aladdin, cat. no. C111535)

• KCl (Aladdin, cat. no. P112133)

• NaOCl (Guangdong Guanghua Sci-Tech Co., Ltd., cat. no.1.01412.018)

[CAUTION!] NaOCl is corrosive and hazardous to environment. Handle with protective gloves.

• HEPES (Shanghai Yuanye Bio-Technology, cat. no. S16013)

• Genapol X-80 (Sigma, cat. no. G6923)

• Imidazole (Solarbio, cat. no. I8090)

[CAUTION!] Imidazole is acutely toxic. Handle with protective gloves.

• Ethanol (Ghtech, cat. no. 1.17113.033)

[CAUTION!] Ethanol is flammable. Avoid flames and handle in a fume hood.

• Hexadecane (Sigma-Aldrich, cat. no. V900147)

• Silicone oil AR20 (Sigma-Aldrich, cat. no. 10838)

• Pentane (Sigma-Aldrich, cat. no. 236705)

[CAUTION!] Hexane is acutely toxic and flammable. Avoid flames and handle in a fume hood.

• 1,2-diphytanoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids, cat. no. 850356)

• Poly T-TEG-biotn (Sangon Biotech, customized product)

• Poly C-TEG-biotn (Sangon Biotech, customized product)

• Streptavidin (New England Biolabs, cat. no. N7021S)

• Ultrapure water (Milli-Q)

• 4%−20% Mini-PROTEAN TGX Gel (Bio-Rad, cat. no. 4561083S)

• Precision Plus Protein™ Dual Xtra Standards (Bio-Rad, 1610374)

• SDS-PAGE sample loading buffer (Beyitime, cat. no. P0015F)

• Coomassie blue fast staining solution (Beyitime, cat. no. P0017)

• Kanamycin solution (10 mg/mL). Dissolve 0.05 g Kanamycin in 5 mL Milli-Q and stir well. Store at −20 °C.

• IPTG solution (1 mol/L). Dissolve 0.4766 g IPTG in 2 mL Milli-Q and stir well. Store at −20 °C.

• LB broth. Dissolve 2.5 g LB broth powder in 100 mL Milli-Q. Autoclave at 121 °C for 15 min and then cool at room temperature. Transfer it to biosafety cabinet. Add 100 μL 10 mg/mL kanamycin solution and stir well. This solution can be stored at 4 °C for one week.

• LB agar plate. Dissolve 3.8 g LB agar in 100 mL Milli-Q. Autoclave at 121 °C for 15 min and then cool to 55 °C at room temperature. Transfer it to biosafety cabinet. Add 100 μL 10 mg/mL kanamycin solution and stir well. Pour the agar evenly into the petri dishes (~25 mL for each plate) and allow each plate to cool until the agar sets and hardens (~10 min). Cover the lid and seal it with the parafilm. This medium can be stored at 4 °C for two weeks.

• Lysis buffer (100 mmol/L Na₂HPO₄/NaH₂PO₄, 0.1 mmol/L EDTA, 150 mmol/L NaCl, 0.5% (w/v) Genapol X-100, pH 6.5). Dissolve 6.0 g NaH₂PO₄, 14.61 mg EDTA, 4.38 g NaCl in 450 mL Milli-Q and stir well. Adjust the pH to 6.5 with HCl. Bring the volume to 500 mL with Milli-Q. Add 2.5 mL Genapol X-80 and stir well. Store at room temperature.

• Binding buffer A (0.5 mol/L NaCl, 20 mmol/L HEPES, 5 mmol/L imidazole, 0.5% (w/v) Genapol X-080, pH = 8.0). Dissolve 14.61 g NaCl, 2.383 g HEPES, 0.17 g imidazole, 2.5 mL Genapol X-080 in 400 mL Milli-Q and stir well. Adjust the pH to 8.0 with NaOH. Bring the volume to 500 mL with Milli-Q. Filter the buffer in the vacuum with a membrane filter. Store at room temperature.

• Elution buffer B (0.5 mol/L NaCl, 20 mmol/L HEPES, 500 mmol/L imidazole, 0.5% (w/v) Genapol X-080, pH = 8.0). Dissolve 14.61 g NaCl, 2.383 g HEPES, 17.0 g imidazole, 2.5 mL Genapol X-080 in 400 mL Milli-Q and stir well. Adjust the pH to 8.0 with NaOH. Bring the volume to 500 mL with Milli-Q. Filter the buffer in the vacuum with a membrane filter. Store at room temperature.

• Hexadecane (0.5% (v/v)). Add 5 μL hexadecane in 995 μL pentane. Stir well and seal the sealing film. Store at −20 °C.

• Lipid (5 mg/mL). Dissolve 25 mg 1,2-diphytanoyl-sn-glycero-3-phosphocholine in 5 mL pentane. Stir well and seal the sealing film. Store at −20 °C.

• KCl buffer (1.5 mol/L KCl, 10 mmol/L HEPES, pH = 7.0). Dissolve 55.9125 g KCl and 1.1915 g HEPES in 400 mL Milli-Q. Adjust the pH to 7.0 with NaOH. Bring the volume to 500 mL with Milli-Q. Filter the buffer in the vacuum with a membrane filter. Store at room temperature.

• Sliver wire (Alfa Aesar, cat. no. 42487)

• AMPLIMITE HDP-20 Male pine (TE Connectivity, cat. no. 66506-4)

• Teflon film (Thickness: 20 µm)

• Syringe filter (Pall corporation, cat. no. 4612)

• Membrane filter (Whatman, cat. no. 7001 004)

• Arc generator (homemade)

• Measurement device (homemade)

• Faraday cage (homemade)

• Ultrapure Water Systems (Millipore)

• Autoclave (Zealway, cat. no. GI54DWS)

• Biosafety cabinet (Airtech, cat. no. BSC-1000IIA2)

• Digital heating cooling drybath (Thermofisher, cat. no. 88880030)

• Thermostatic incubator (Senxin, cat. no. DRP-9052)

• Full temperature double layer oscillating incubator (PeiYing, cat. no. HZQ-F100)

• Sorvall ST 8R small benchtop bentrifuge (Thermofisher, cat. no. 75007204)

• ÄKTA pure protein purification system (Cytiva)

• HisTrap^TMHP nickel ion affinity column (GE Healthcare)

• Mini vertical electrophoresis apparatus (Baygene, cat. no. BG-verMINI)

• BG-verMINI electrophoresis dystem (Baygene, cat. no. BG-Power600h)

• G:BOX F3 gel documentation dystem (Syngene)

• Stereo microscope (Nanjing Jiangnan Novel Optics Co., Ltd, cat. no. JSZ6S)

• Axopatch 200B amplifier (Molecular Devices)

• Axon digidata 1550B (Molecular Devices)

• Optical table (Jiangxi Liansheng technology Co., Ltd., cat. no. ZDT09-06)

E. coli　　Escherichia coli

IPTG　　 Isopropyl-β-D thiogalactoside

LB　　　 Lysogeny broth

MspA　　Mycobacterium smegmatis porin A